ArcticZymes has secured its first supply agreement for the utility of Salt Active Nuclease High Quality (SAN HQ) in the cGMP manufacturing of viruses for gene therapy. ArcticZymes’ Novel SAN HQ enzyme offers gene therapy and vaccine customers a more cost effective and technically superior solution for removing contaminating DNA during the manufacturing process of therapeutic viruses. This represents […]
Data from collaboration among NRGene, China’s Xi’an Jiaotong University, and The Wellcome Sanger Institute and The University of York, UK Shaanxi, China; York, UK, & Ness Ziona, Israel – Xi’an Jiaotong University, The Wellcome Sanger Institute, The University of York, and NRGene have recently completed the world’s first assembly of the opium poppy genome. “We’re using the genome to […]
DNA Script Announces World’s First Enzymatic Synthesis of a High-Purity 150-Nucleotide Strand of DNA
DNA Script’s approach achieves parity with conventional chemical synthesis — and is poised to quickly surpass the current gold standard in speed, efficacy and length for commercial DNA synthesis. SAN FRANCISCO, Calif.–DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced that it has successfully synthesized the world’s first 150-nucleotide (nt) […]
£1.25 million already secured based on pre-money valuation of £18.2 million Additional funding will be used to further accelerate product development and company growth Daresbury, UK: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced the closing of a £1.25 million investment round and a decision to overfund by an additional £0.5 million, […]
LineaRx offers simplified manufacturing path to RNA Biotherapeutics via linear DNA STONY BROOK N.Y. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA), the leader in large-scale PCR-based DNA manufacturing, announced today that LineaRx, Inc. (“LineaRx” ” or the “Company”), its wholly-owned subsidiary focused on next-generation biotherapeutics, has secured multiple new developers of RNA therapeutics as customers for […]
Demonstrating continued growth as a global market leader in rapid and portable microbiological monitoring tools, LuminUltra has acquired aqua-tools’ Rapid Microbial Solutions division, including its B-QUA™ product line for ballast water compliance monitoring and the European customer base for its 2nd Generation ATP®(Adenosine Triphosphate) measurement products. This acquisition closed today. This is the second significant acquisition […]
Today, LGC Axolabs announces a significant investment at its site at Kulmbach, Germany, to expand the capacity of its specialist therapeutic oligonucleotide development solutions business and create a new GMP analytical capability. Due to open in February 2019, the new 800m² labs comprise additional bioanalysis and synthetic chemistry labs as well as a new GMP […]
Collaboration will focus on the development of a bespoke silicon array to enable high-throughput production of high-fidelity gene-length DNA DNA synthesis at this level will allow applications in the rapidly growing field of synthetic biology to become a reality CAMBRIDGE, UK, and ENSCHEDE, The Netherlands – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to […]
Approval allows use of therascreen® EGFR RGQ PCR Kit as a companion diagnostic for Pfizer’s VIZIMPRO® (dacomitinib) in patients with non-small cell lung cancer Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved a PMA Supplement expanding the labelling […]
Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has now gained exclusive rights to the ChIPmentation technology which it launched late last year from the Research Center of Molecular Medicine of the Austrian Academy of Sciences (CEMM). The ChIPmentation system encompasses a unique methodology that integrates chromatin immunoprecipitation with […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
